O-(chloroacetylcarbamoyl)fumagillol (TNP-470) has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, and Pancreatic Neoplasms.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.